decision-sha256: b45a17a342bfa49689c3571e71c14ab55c2fa64e0f9337032876739babdae205
actor: audit-codex-2026-09-06T043454Z-6f31d86e5b7d-r5
model: gpt-5.6-terra
family: openai
verdict: approve
unresolved-findings: none

## Rerun

I replayed the decision's non-mutating source, GitHub API, disclosure, source-precedent, and `actionlint` probes from this R18 bundle on macOS. The exact argv and complete captured output are in `review/evidence/audit-ai-assisted-review-workflows-r5.log`. The stated recovery scan could not run because this isolated bundle has no `scripts/research_scan.py`. `limactl` is available, but its `ubuntu` instance is stopped; I did not start it under the no-action constraint. The successful source and fixture checks exited 0. The negative `actionlint` control exited 1 as expected, and the pinned `ts` `grep` control exited 1 after printing 0 as expected. One current GitHub Docs raw-file URL from the old capture returned 404; it is documentation-path drift, not a contrary result. The replay otherwise matches the decision's decisive tagged-source, API, raw-report, fixture, and unproven-item claims.

## Findings

No acceptance-blocking finding.

1. The conditional recommendation is evidence-supported. The source reads at the immutable `v1.0.220` tag resolve it to commit `19dda84776b3518d98b8798e591daee763049ed3`. The decision does not claim a live template, configured App, credential, skipped-job outcome, prefilter runtime outcome, review-token scope, or replacement-prompt behavior. Those gaps are separately represented as U1--U18 with P03 proof actions.
2. The guard-table correction is correct. `prepare.ts` calls `setupGitHubToken()` at line 37 before `checkWritePermissions()` at line 44; the per-mode `checkHumanActor` calls occur later at tag line 43 and agent line 30. The assistant fixture supplies `additional_permissions: actions: read`; `action.yml` maps that input to `ADDITIONAL_PERMISSIONS`, and `token.ts` merges any nonempty parsed value with default `contents`, `pull_requests`, and `issues` write permissions before exchanging the OIDC token. The decision correctly treats the review lane's server-chosen token scope as U17 rather than calling it read-only.
3. The subprocess-scrub statement is correct. At the pin, the environment value resolves from `allowed_non_write_users != ''`, and its Linux dependency-install step has the same nonempty-input gate. The recommended fixtures leave that input empty and do not set the environment override. The scrub is available but inactive; U16 honestly leaves the unsupported half-state unresolved.
4. The marketplace conclusion is correct and its removal is complete. `MARKETPLACE_URL_REGEX` accepts only URLs ending in `.git`, excluding a suffix ref or fragment; `installPlugins` follows workload-identity setup; the live repository default branch is `main`; and its marketplace JSON supplies the plugin name. The r4 fixtures contain no active `plugin_marketplaces` or `plugins` key. Historical mentions in the decision and fixture comments explain the removed configuration and are not active inputs. The tag's own maintainer review workflow instead uses a pinned-tree `/review-pr` command. U18 correctly withholds any claim that the template-local replacement works or is equivalent.
5. The eighteen unproven items are honest. They distinguish source-verified syntax and topology from runtime, billing, authorization, App-token scope, review-quality, and owner-choice claims. None is silently treated as settled by the recommendation. R18 owns no parameter; the revision-5 four `assumes` lines exactly match the fixed registry values and contain no publication-breaking commentary.

## Assessment

The evidence supports the recommendation as it now stands: ship both files only as inert P03 artifacts, with no enablement on any public repository until the owner records acceptance of the explicitly named residual; if acceptance is withheld, ship neither file and publish the opt-in recipe. This is not approval to implement, configure credentials, enable either workflow, or perform a live validation. It is approval of the P02 research decision's evidence boundaries and conditional recommendation.
